Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshito Akagi

Showing results (221-230 of 261) with videos related to

Pageof 27
Sort By:
International Journal of Clinical Oncology|January 14, 2012
Initial report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japanese patientsYasunori Emi, Yoshihiro Kakeji, Eiji Oki, et al.
Cancer Medicine|November 29, 2020
Trifluridine/tipiracil plus bevacizumab as a first-line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): A multicenter phase II trialEiji Oki, Akitaka Makiyama, Yuji Miyamoto, et al.
Molecular and Clinical Oncology|March 26, 2021
Investigation of clinicopathological characters and gene expression features in colorectal signet-ring cell carcinoma utilizing CMS classificationKensuke Tajiri, Tomoya Sudo, Kazuo Ishi, et al.
Cancer Chemotherapy and Pharmacology|December 13, 2016
Phase II trial of capecitabine plus modified cisplatin (mXP) as first-line therapy in Japanese patients with metastatic gastric cancer (KSCC1104)Hironaga Satake, Masaaki Iwatsuki, Yoshikazu Uenosono, et al.
Anticancer Research|November 5, 2014
Liver resectability of advanced liver-limited colorectal liver metastases following mFOLFOX6 with bevacizumab (KSCC0802 Study)Toru Beppu, Yasunori Emi, Shoji Tokunaga, et al.
Cancer Immunology Research|October 30, 2014
Phase II study of personalized peptide vaccination for previously treated advanced colorectal cancerShiro Kibe, Shigeru Yutani, Satoru Motoyama, et al.
Medicine|April 22, 2022
Assessing the incidence of complications and malignancies in the long-term management of benign biliary strictures with a percutaneous transhepatic drainMunehiro Yoshitomi, Ryuichi Kawahara, Shinichi Taniwaki, et al.
Cancer Medicine|November 29, 2016
Muscle RAS oncogene homolog (MRAS) recurrent mutation in Borrmann type IV gastric cancerMakiko Yasumoto, Etsuko Sakamoto, Sachiko Ogasawara, et al.
Anticancer Research|August 2, 2019
Clinical and Prognostic Significance of Neoplastic Spindle Cells in Gallbladder CancerRyuta Midorikawa, Toru Hisaka, Hisamune Sakai, et al.
Anticancer Research|July 31, 2020
Quercetin Suppresses Proliferation of Liver Cancer Cell Lines <i>In Vitro</i>Toru Hisaka, Hisamune Sakai, Toshihiro Sato, et al.
Pageof 27

Showing results (221-230 of 261) with videos related to

Sort By:
Pageof 27
International Journal of Clinical Oncology|January 14, 2012
Initial report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japanese patientsYasunori Emi, Yoshihiro Kakeji, Eiji Oki, et al.
Cancer Medicine|November 29, 2020
Trifluridine/tipiracil plus bevacizumab as a first-line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): A multicenter phase II trialEiji Oki, Akitaka Makiyama, Yuji Miyamoto, et al.
Molecular and Clinical Oncology|March 26, 2021
Investigation of clinicopathological characters and gene expression features in colorectal signet-ring cell carcinoma utilizing CMS classificationKensuke Tajiri, Tomoya Sudo, Kazuo Ishi, et al.
Cancer Chemotherapy and Pharmacology|December 13, 2016
Phase II trial of capecitabine plus modified cisplatin (mXP) as first-line therapy in Japanese patients with metastatic gastric cancer (KSCC1104)Hironaga Satake, Masaaki Iwatsuki, Yoshikazu Uenosono, et al.
Anticancer Research|November 5, 2014
Liver resectability of advanced liver-limited colorectal liver metastases following mFOLFOX6 with bevacizumab (KSCC0802 Study)Toru Beppu, Yasunori Emi, Shoji Tokunaga, et al.
Cancer Immunology Research|October 30, 2014
Phase II study of personalized peptide vaccination for previously treated advanced colorectal cancerShiro Kibe, Shigeru Yutani, Satoru Motoyama, et al.
Medicine|April 22, 2022
Assessing the incidence of complications and malignancies in the long-term management of benign biliary strictures with a percutaneous transhepatic drainMunehiro Yoshitomi, Ryuichi Kawahara, Shinichi Taniwaki, et al.
Cancer Medicine|November 29, 2016
Muscle RAS oncogene homolog (MRAS) recurrent mutation in Borrmann type IV gastric cancerMakiko Yasumoto, Etsuko Sakamoto, Sachiko Ogasawara, et al.
Anticancer Research|August 2, 2019
Clinical and Prognostic Significance of Neoplastic Spindle Cells in Gallbladder CancerRyuta Midorikawa, Toru Hisaka, Hisamune Sakai, et al.
Anticancer Research|July 31, 2020
Quercetin Suppresses Proliferation of Liver Cancer Cell Lines <i>In Vitro</i>Toru Hisaka, Hisamune Sakai, Toshihiro Sato, et al.
Pageof 27